Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorMATAS, Carla Gentile
dc.contributor.authorSAMELLI, Alessandra Giannella
dc.contributor.authorMAGLIARO, Fernanda Cristina Leite
dc.contributor.authorSEGURADO, Aluisio
dc.identifier.citationBRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY, v.84, n.5, p.574-582, 2018
dc.description.abstractIntroduction: The Human Immunodeficiency Virus (HIV) and infections related to it can affect multiple sites in the hearing system. The use of High Activity Anti-Retroviral Therapy (HAART) can cause side effects such as ototoxicity. Thus, no consistent patterns of hearing impairment in adults with Human Immunodeficiency Virus / Acquired Immune Deficiency Syndrome have been established, and the problems that affect the hearing system of this population warrant further research. Objectives: This study aimed to compare the audiological and electrophysiological data of Human Immunodeficiency Virus-positive patients with and without Acquired Immune Deficiency Syndrome, who were receiving High Activity Anti-Retroviral Therapy, to healthy individuals. Methods: It was a cross-sectional study conducted with 71 subjects (30-48 years old), divided into groups: Research Group I: 16 Human Immunodeficiency Virus-positive individuals without Acquired Immunodeficiency Syndrome (not receiving antiretroviral treatment); Research Group II: 25 Human Immunodeficiency Virus-positive individuals with Acquired Immunodeficiency Syndrome (receiving antiretroviral treatment); Control Group: 30 healthy subjects. All individuals were tested by pure-tone air conduction thresholds at 0.25-8 kHz, extended high frequencies at 9-20 kHz, electrophysiological tests (Auditory Brainstem Response, Middle Latency Responses, Cognitive Potential). Results: Research Group I and Research Group II had higher hearing thresholds in both conventional and high frequency audiometry when compared to the control group, prolonged latency of waves I, III, V and interpeak I-V in Auditory Brainstem Response and prolonged latency of P300 Cognitive Potential. Regarding Middle Latency Responses, there was a decrease in the amplitude of the Pa wave of Research Group II compared to the Research Group I. Conclusions: Both groups with Human Immunodeficiency Virus had higher hearing thresholds when compared to healthy individuals (group exposed to antiretroviral treatment showed the worst hearing threshold) and seemed to have lower neuroelectric transmission speed along the auditory pathway in the brainstem, subcortical and cortical regions. (C) 2018 Associacao Brasileira de Otorrinolaringologia e Cirurgia Cervico-Facial.
dc.description.sponsorshipFAPESP (Foundation for Research Support of the State of Sao Paulo) [55156-9]
dc.relation.ispartofBrazilian Journal of Otorhinolaryngology
dc.subjectAcquired immunodeficiency syndrome
dc.subjectAuditory evoked potentials
dc.subjectHearing loss
dc.titleAudiological and electrophysiological alterations in HIV-infected individuals subjected or not to antiretroviral therapy
dc.type.categoryoriginal article
hcfmusp.publisher.citySAO PAULO
hcfmusp.relation.referenceANDERS KH, 1986, AM J PATHOL, V124, P537
hcfmusp.relation.referenceBANKAITIS AE, 1995, EAR HEARING, V16, P321, DOI 10.1097/00003446-199506000-00009
hcfmusp.relation.referenceBankaitis Aukse E., 1998, Seminars in Hearing, V19, P177, DOI 10.1055/s-0028-1082967
hcfmusp.relation.referenceBungener C, 1996, PROG NEURO-PSYCHOPH, V20, P1303, DOI 10.1016/S0278-5846(96)00127-3
hcfmusp.relation.referenceCampanini A, 2005, Acta Otorhinolaryngol Ital, V25, P30
hcfmusp.relation.referenceCastello E, 1998, ANN OTO RHINOL LARYN, V107, P1054, DOI 10.1177/000348949810701210
hcfmusp.relation.referenceCastro NM, 2000, REV CLIN ESP, V200, P271
hcfmusp.relation.referenceChandrasekhar SS, 2000, AM J OTOLARYNG, V21, P1, DOI 10.1016/S0196-0709(00)80117-9
hcfmusp.relation.referenceColebunders R, 1998, EUR J CLIN MICROBIOL, V17, P214, DOI 10.1007/BF01691123
hcfmusp.relation.referenceDOURNON E, 1988, LANCET, V2, P1297
hcfmusp.relation.referenceFEIN G, 1995, ARCH NEUROL-CHICAGO, V52, P1109, DOI 10.1001/archneur.1995.00540350103022
hcfmusp.relation.referenceFokouo JVF, 2015, JAMA OTOLARYNGOL, V141, P436, DOI 10.1001/jamaoto.2015.125
hcfmusp.relation.referenceGurney TA, 2003, OTOLARYNG CLIN N AM, V36, P607, DOI 10.1016/S0030-6665(03)00031-8
hcfmusp.relation.referenceJuan K., 2009, AVALIACAO AUDIOLOGIC
hcfmusp.relation.referenceKOHAN D, 1988, ANN OTO RHINOL LARYN, V97, P636, DOI 10.1177/000348948809700611
hcfmusp.relation.referenceLin C, 2013, JAMA OTOLARYNGOL, V139, P251, DOI 10.1001/jamaoto.2013.1709
hcfmusp.relation.referenceLloyd LL, 1978, AUDIOMETRIC INTERPRE
hcfmusp.relation.referenceMaro II, 2014, EAR HEARING, V35, P306, DOI 10.1097/01.aud.0000439101.07257.ed
hcfmusp.relation.referenceMatas Carla Gentile, 2006, Pró-Fono R. Atual. Cient., V18, P171, DOI 10.1590/S0104-56872006000200006
hcfmusp.relation.referenceMinisterio da Saude. Coordenacao Nacional DST/AIDS, 1999, J BRAS DOENCAS SEX T, V11, P31
hcfmusp.relation.referencePalacios GC, 2008, INT J PEDIATR OTORHI, V72, P1671, DOI 10.1016/j.ijporl.2008.08.002
hcfmusp.relation.referencePAPPAS DG, 1994, AM J OTOL, V15, P456
hcfmusp.relation.referencePierelli F, 1996, ACTA NEUROL SCAND, V93, P266
hcfmusp.relation.referencePolich J, 2000, INT J PSYCHOPHYSIOL, V38, P97, DOI 10.1016/S0167-8760(00)00133-1
hcfmusp.relation.referenceRAREY KE, 1990, AM J OTOLARYNG, V11, P366, DOI 10.1016/0196-0709(90)90113-A
hcfmusp.relation.referenceReis AC, 2007, EPIDEMIOL SERV SAUDE, V16, P195
hcfmusp.relation.referenceRey D, 2002, CLIN INFECT DIS, V34, P418, DOI 10.1086/324368
hcfmusp.relation.referenceReyes-Contreras L, 2002, ARCH MED RES, V33, P25, DOI 10.1016/S0188-4409(01)00342-3
hcfmusp.relation.referenceSerafini G, 1998, Rev Laryngol Otol Rhinol (Bord), V119, P87
hcfmusp.relation.referenceSilman S, 1997, AUDITORY DIAGNOSIS P, P44
hcfmusp.relation.referenceSilva Aline Covo da, 2007, Pró-Fono R. Atual. Cient., V19, P352, DOI 10.1590/S0104-56872007000400005
hcfmusp.relation.referenceTartar JL, 2004, NEUROREPORT, V15, P1675, DOI 10.1097/01.wnr.0000134992.74181.4b
hcfmusp.relation.referenceThein P, 2014, HEARING RES, V310, P27, DOI 10.1016/j.heares.2014.01.005
hcfmusp.relation.referenceTorre P, 2015, JAMA OTOLARYNGOL, V141, P202, DOI 10.1001/jamaoto.2014.3302
hcfmusp.relation.referenceUNAIDS, 2010, GLOB REP UNAIDS REP
hcfmusp.relation.referencevan der Westhuizen Y, 2013, INT J AUDIOL, V52, P37, DOI 10.3109/14992027.2012.721935
hcfmusp.relation.referenceVieira ABC, 2010, REV MED MINAS GERAIS, V20, P102
hcfmusp.relation.referenceWilkin TJ, 2008, CLIN INFECT DIS, V47, P1580, DOI 10.1086/593311
hcfmusp.relation.referenceWilliams B, 2001, CLIN INFECT DIS, V33, P2100, DOI 10.1086/324361
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MFT
Departamento de Fisioterapia, Fonoaudiologia e Terapia Ocupacional - FM/MFT

Artigos e Materiais de Revistas Científicas - FM/MIP
Departamento de Moléstias Infecciosas e Parasitárias - FM/MIP

Artigos e Materiais de Revistas Científicas - HC/ICHC
Instituto Central - HC/ICHC

Artigos e Materiais de Revistas Científicas - LIM/34
LIM/34 - Laboratório de Ciências da Reabilitação

Artigos e Materiais de Revistas Científicas - LIM/49
LIM/49 - Laboratório de Protozoologia

Artigos e Materiais de Revistas Científicas - ODS/03
ODS/03 - Saúde e bem-estar

Artigos e Materiais de Revistas Científicas - ODS/05
ODS/05 - Igualdade de gênero

Files in This Item:
File Description SizeFormat 
art_MATAS_Audiological_and_electrophysiological_alterations_in_HIVinfected_individuals_subjected_2018.PDFpublishedVersion (English)631.42 kBAdobe PDFThumbnail

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.